Cancer can be prevented. Identifying and managing genetic mutations before they evolve into cancer saves patients lives.
WE ARE MEDNEON
The innovative Medneon digital AI platform curates up-to-date, actionable and personalized information regarding an individual’s risk of developing cancer and generates insights on appropriate preventive and management strategies over time.
PREDICTIVE RISK ASSESSMENT™
PERSONALIZED GENETIC INSIGHTS™
PATIENT REVIEW BOARD™
REALIGNING PATIENTS, CLINICIANS, INDUSTRY PARTNERS AND PAYERS
Our priorities are aligned with the best outcomes and quality of life for patients, more satisfying work for clinicians, and the lowest costs for payers.
ANALYZE, VISUALIZE, REPORT, & MANAGE REAL-WORLD EVIDENCE.
Join us at ASBrS 2019 Annual Meeting April 30 – May 5 in Dallas, TX, Booth #353